CLINICAL EVENTS CALENDAR
Non-Accredited Education
CLINICAL EXPERIENCE WITH A NEW HYBRID CORONARY WIRE On Demand Web ArchiveNon-Accredited Target Audience: Physicians, nurses, and technologists. This activity is supported by an educational grant from Terumo Medical Corporation. |
Issue
- Issue Number:3: March 2004
ABSTRACT: Background. The long-term prognosis of diabetic patients with multivessel coronary artery disease (CAD) treated by surgical or percutaneous coronary revascularization is significantly worse as compared to non-diabetics. Lower rates of complete revascularization may be one factor that influences the poor long-term outcome in the diabetic population. Our study assessed the impact of complete revascularization on the long-term prognosis in diabetic patients with CAD treated by percutaneous coronary intervention (PCI). The study included 658 consecutive diabetic patients (mean age, 60.9 ± 10.1 years) who underwent PCI. Multivessel disease was present in 352 patients (53.5%). Revascularization was complete in 94 (26.7%) and incomplete in 258 (73.3%) patients with multivessel disease.
- Issue Number:3: March 2004
Percutaneous coronary interventions (PCI) have been increasingly adopted for the treatment of coronary artery disease in patients with diabetes mellitus.
- Issue Number:3: March 2004
ABSTRACT: This study evaluated specially designed perfluorocarbon (PFC) emulsions as blood substitutes in case of induced ischemia of the left heart ventricle in healthy farm pigs. Two hundred milliliters of perfluorocarbon emulsion were infused while 200 ml of blood were simultaneously drawn. Radiographic contrast media were given to aid placement of balloon catheters in the left coronary artery. Histopathological analysis showed that right heart failure caused the deaths of both pigs. Particles (up to > 3 µm) of foreign body materials obstructed capillaries of all organs analyzed (heart, lung, liver, kidneys and spleen). Laboratory investigation showed severe interference between the PFC emulsion and radiographic contrast media, resulting in the deterioration of the PFC emulsion. The strongest interference occurred when PFC emulsion and Accupaque® interacted; particle size started at an initial 311 nm and went up to > 3 µm within seconds.
- Issue Number:3: March 2004
ABSTRACT: Although numerous studies have established the utility of 4 French (Fr) catheters for routine coronary angiography, its adequacy for automatic quantitative coronary analysis has not been previously assessed. Methods. In 32 consecutive patients, coronary angiography was performed sequentially with 4 Fr diagnostic catheters and 6 Fr guiding catheters after intracoronary nitroglycerin. A total of 43 lesions were evaluated for quantitative analysis using both types of catheter as scaling devices. Possible differences in the reference diameter, minimal luminal diameter and percent diameter stenosis were evaluated. All measurements were performed offline by the same operator and intraobserver variability estimation was performed by repeating the evaluation in 12 lesions randomly selected after 1 month. Results. The mean reference diameter was 2.98 ± 0.48 mm, mean minimal luminal diameter was 1.00 ± 0.52 mm and percent diameter stenosis was 67.1 ± 15.3%.
- Issue Number:3: March 2004
ABSTRACT: The aim of this study was to evaluate the feasibility, safety and efficacy of transcatheter closure of secundum atrial septal defects (ASD) in patients with complex anatomy. From September 1997 to July 2003, a total of 40 patients (median age, 34 years; 65% female) with complex ASDs, defined as the presence of a large defect (stretched diameter > 26 mm) associated with a deficient rim (n = 23); multiple defects (n = 8); a multi-fenestrated septum (n = 5); and defects associated with an aneurysmal septum irrespective of their size (n = 4) underwent closure. The Helex device was used in 4 patients and the Amplatzer in the remaining. Two devices were implanted in 2 patients each. Implantation was unsuccessful in 5 patients, with 4 having large defects associated with a deficient anterior rim and a floppy posterior septum. Occlusion was observed in 22/35 patients (63%) immediately after implantation and in 31 (89%) at a mean follow-up of 18 ± 9 months.
- Issue Number:3: March 2004
Since the pioneering investigations by King, Rashkind and their colleagues1–6 in mid 1970s of percutaneous device occlusion of secundum atrial septal defects (ASDs), a number of other investigators have designed and tested other devices as reviewed elsewhere.7,8 The interventional cardiologist has therefore, lots of devices to choose from. But the selection of one device over the other is difficult because of lack of prospective randomized clinical trials.9,10 Such trials involving all the eligible devices is necessary to provide accurate information on usefulness of the devices. The present medical, ethical, regulatory and economic considerations are unlikely to result in such clinical trials. Therefore, the choice of the device has to be based on results of large cohorts of implantations of individual devices, sponsored by the manufacturer of the devices.
- Issue Number:3: March 2004
ABSTRACT: Heart catheterization is frequently applied in patients with coronary artery disease for diagnostic and therapeutic implications. Using the femoral approach, post-procedure bed rest of 4–6 hours is recommended to prevent groin complications. This extended strict bed rest is associated with patient discomfort and increased medical costs, and interferes with more efficient catheterization laboratory management of referred outpatients. Accordingly, we tested a simple clinical approach to identify low-risk patients who may benefit from ambulation within two hours after sheath removal. Ninety-eight outpatients were stratified to early (time = 1.5–2.0 hours; n = 74) or conventional ambulation (time = 4–5 hours; n = 24) based on difficulties in obtaining arterial access, presence of oozing or hematoma after completing manual compression.
- Issue Number:3: March 2004
ABSTRACT: Transradial percutaneous coronary intervention (PCI) is a safe and effective method of percutaneous revascularization. However, there are no data on the efficacy of the transradial approach in left main (LM) PCI. We studied 80 patients (pts) who underwent LM PCI between February 1994 and January 2002, and compared the radial (27 pts) and femoral (53 pts) approaches. Patients were considered free of restenosis if they were free of angina and had a negative treadmill or nuclear imaging study 6 months post-PCI. Mean follow-up time was 27.4 ± 23.0 months. Reason for PCI (stable angina, unstable angina, acute myocardial infarction) and lesion location (ostial, mid, distal) were similar in both groups (p > 0.05), whereas mean ejection fraction was higher in the radial group (56.5 ± 11.1% versus 49.2 ± 14.7%, respectively; p < 0.05).
- Issue Number:3: March 2004
ABSTRACT: We describe a case of carotid artery restenosis following carotid artery stenting for treatment of post-endarterectomy stenosis. The goal is to highlight the risk of recurrent restenosis following endarterectomy. In this case report, we describe the use of cutting balloon therapy as a reasonable alternative to repeat surgical revascularization.
Key words: arteriosclerosis, cerebrovascular disorders, endarterectomy
All Subscriptions are FREE to qualified cardiology professionals

- Subscribe to:
- Journal
- Digital Journal
- E-News
- RSS feed
Anytown, California
CME Showcase
![]() The Use of Remote Robotic Navigation in Complex Arrhythmias Complimentary Accredited Web Archive This activity is designed for electrophysiologists and EP allied professionals. Diagnosing Coronary Artery Disease: Advanced Cardiovascular Imaging Solutions Treatment Options for the AF Patient A-fib Ablation: New Standards of Care for CRMD Antibiotic Protection Complimentary CME Accredited Webcast Dates: November 18, 2008 Time: 6:00 pm ET November 19, 2008 Time: 3:00 pm ET This activity is sponsored by the North American Center for Continuing Medical Education. |
LUMEN 2009 - THE SYMPOSIUM ON OPTIMAL TREATMENTS FOR ACUTE MI Live Symposium Date: February 26-28 Location: Loews Miami Beach Hotel Miami Beach, Florida 33139 This activity is sponsored by the North American Center for Continuing Medical Education. |
CARDIAC PET: Optimizing CAD Patient Management with Diagnostic Confidence A Complimentary CME Accredited Lunch Symposium Date: Friday, September 12, 2008 12:00 pm - 1:15 pm Location: Hynes Convention Center 900 Boylston Street, Room 304 Boston, MA 02115 This activity is supported by an educational grant from Bracco Diagnostics Inc. |










